Anna K. H. Hirsch, Ph.D.
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
Anna K. H. Hirsch, Ph.D., is head of the department for drug design and optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and full professor of medicinal chemistry at Saarland University. She read natural sciences at the University of Cambridge and carried out her master’s research project in the group of Professor Steven V. Leyand. She spent her third year at the Massachusetts Institute of Technology.
She received her Ph.D. from ETH Zürich in 2008 in the group of Professor François Diederich. Subsequently, she joined the group of Professor Jean-Marie Lehn at the Institut de Science et d’Ingénierie Supramoléculaires in Strasbourg, before taking up a position as assistant professor at the Stratingh Institute for Chemistry at the University of Groningen in 2010, where she was promoted to associate professor in 2015.
Her work focuses on target based anti-infective drug discovery and protein-templated hit-identification strategies. She has authored more than 130 peer-reviewed papers and has received numerous awards such as the Gratama Science Prize, the SCT-Servier Prize for Medicinal Chemistry, the Innovation Prize for Medicinal Chemistry of the GdCh/DPhG and the EFMC Young Medicinal Chemist in Academia runner-up Prize.
She received her Ph.D. from ETH Zürich in 2008 in the group of Professor François Diederich. Subsequently, she joined the group of Professor Jean-Marie Lehn at the Institut de Science et d’Ingénierie Supramoléculaires in Strasbourg, before taking up a position as assistant professor at the Stratingh Institute for Chemistry at the University of Groningen in 2010, where she was promoted to associate professor in 2015.
Her work focuses on target based anti-infective drug discovery and protein-templated hit-identification strategies. She has authored more than 130 peer-reviewed papers and has received numerous awards such as the Gratama Science Prize, the SCT-Servier Prize for Medicinal Chemistry, the Innovation Prize for Medicinal Chemistry of the GdCh/DPhG and the EFMC Young Medicinal Chemist in Academia runner-up Prize.